Lowell Farms Inc. Announces First Quarter 2021 Financial Results
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Transformative, leading allogeneic NKT cell platform technology expands Athenex’s cell therapy development capability Platform has…
New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque…
SAN CARLOS, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Multiple pre-clinical studies indicate that Lixte’s lead clinical drug candidate LB-100 enhances the effectiveness of…
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 Conference…
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
COPENHAGEN, Denmark, May 04, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention…
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Prescription Growth Reflects Increasing Demand for Twirla Base of Prescribers Continues to Grow in First…
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
Imsidolimab Phase 3 GPP trial anticipated to commence in mid-2021 following FDA end-of-Phase 2 meeting held…
EMERYVILLE, Calif., May 04, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage…
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in…
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., May 04,…
– Conference call and webcast at 4:30 pm EDT today – – Luxeptinib Phase 1…
TORONTO, May 04, 2021 (GLOBE NEWSWIRE) — Data On Tap Inc. (dotmobile), Canada’s first Full…